ストックスクリーナーアプリを入手
4.39
11.11%
0.52
前日終値:
$3.87
開ける：
$3.96
24時間の取引高:
73,819
Relative Volume:
1.03
時価総額：
$3.16M
収益：
$4.79M
当期純損益:
$-13.42M
株価収益率:
-1.092
EPS:
-4.02
ネットキャッシュフロー:
$-10.30M
1週間 パフォーマンス:
+5.91%
1か月 パフォーマンス:
-52.88%
6か月 パフォーマンス:
-69.78%
1年 パフォーマンス:
-87.55%
1日の値動き範囲:
$3.8154
$4.50
1週間の範囲:
$3.3358
$4.50
52週間の値動き範囲:
$3.3358
$39.13
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
名前
Qualigen Therapeutics Inc
セクター
電話
(760) 918-9165
住所
2042 CORTE DEL NOGAL, CALIFORNIA
QLGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| QLGN | 4.39 | 3.16M | 4.79M | -13.42M | -10.30M | -4.02 |
| VRTX | 450.21 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.87 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 599.22 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.97 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.47 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Qualigen Therapeutics Inc (QLGN) 最新ニュース
Qualigen Therapeutics secures $4.5 million in funding By Investing.com - Investing.com South Africa
Qualigen Therapeutics secures $4.5 million in funding - Investing.com India
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares - GlobeNewswire
Qualigen Therapeutics (NASDAQ:QLGN) versus Ionis Pharmaceuticals (NASDAQ:IONS) Head-To-Head Review - Defense World
Qualigen Therapeutics Inc (QLGN) Quarterly 10-Q Report - Quartzy
Qualigen Therapeutics appoints new board member - Investing.com
Qualigen Therapeutics appoints new board member By Investing.com - Investing.com Canada
QLGN Stock Touches 52-Week Low at $3.71 Amid Market Challenges - Investing.com Canada
Qualigen Therapeutics announces 1-for-50 reverse stock split - Investing.com India
Qualigen Therapeutics announces 1-for-50 reverse stock split By Investing.com - Investing.com UK
Qualigen Therapeutics (STU:7R90) Enterprise Value : €4.58 Mil (As of Nov. 07, 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Operating Cash Flow per Sh - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Shares Outstanding (EOP) : 0.19 Mil (As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Long-Term Debt & Capital L - GuruFocus.com
Qualigen Therapeutics (STU:7R90) EV-to-Revenue : (As of Nov. 07, 2024) - GuruFocus.com
Qualigen Therapeutics (STU:7R90) Cash Flow from Financing : €1.51 Mil (TTM As of Jun. 2024) - GuruFocus.com
Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Qualigen Therapeutics, Inc. Announces Appointment of Amy Broidrick as Executive Vice President and Chief Strategy Officer - Marketscreener.com
QLGN stock touches 52-week high at $5.05 amid market fluctuations - Investing.com
Qualigen Therapeutics Stock to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN) - Defense World
Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewswire
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split - TipRanks
Would I Buy Qualigen Therapeutics Inc (NASDAQ: QLGN) Stock At Any Time In The Future? - Stocks Register
Qualigen Therapeutics announces results of annual stockholder meeting By Investing.com - Investing.com Australia
Qualigen Therapeutics announces results of annual stockholder meeting - Investing.com India
Qualigen Therapeutics (STU:7R9) Enterprise Value : €4.47 Mil (As of Oct. 26, 2024) - GuruFocus.com
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG - openPR
QLGN stock touches 52-week low at $0.11 amid market challenges - Investing.com India
Qualigen Therapeutics faces Nasdaq delisting notice By Investing.com - Investing.com Canada
Qualigen Therapeutics faces Nasdaq delisting notice - Investing.com India
Qualigen Therapeutics (NASDAQ:QLGN) Shares Up 4.4% – Here’s Why - Defense World
Qualigen Therapeutics appoints new director and audit chair By Investing.com - Investing.com South Africa
Qualigen Therapeutics appoints new director and audit chair - Investing.com India
Qualigen Therapeutics sees major executive reshuffle By Investing.com - Investing.com Canada
Qualigen Therapeutics, Inc. Announces management changes. - The Manila Times
Qualigen Therapeutics appoints new leadership amid strategic shift By Investing.com - Investing.com South Africa
Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Sees Large Decline in Short Interest - Defense World
Qualigen Therapeutics sees major executive reshuffle - Investing.com
Qualigen Therapeutics appoints new leadership amid strategic shift - Investing.com
Qualigen Therapeutics Announces Executive Shakeup and Board Revamp - TipRanks
Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex
Qualigen Therapeutics granted Nasdaq listing extension - Investing.com
Qualigen Therapeutics granted Nasdaq listing extension By Investing.com - Investing.com Australia
Qualigen Therapeutics receives extension from Nasdaq hearings panel - TipRanks
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewswire
Qualigen Therapeutics Inc (QLGN) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):